Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Current Opinion in Pediatrics|September 24, 2010
Pharmacogenomics in pediatric leukemiaSteven W Paugh, Gabriele Stocco, William E EvansMolecular & Cellular Oncology|June 17, 2016
Inflammasome-mediated glucocorticoid resistance: The receptor rheostatSteven W Paugh, Erik J Bonten, William E EvansPharmacological Reviews|June 17, 2008
"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targetsKazuaki Takabe, Steven W Paugh, Sheldon Milstien, et al.Wiley Interdisciplinary Reviews. Systems Biology and Medicine|May 25, 2013
Mathematical modeling of folate metabolismJohn C Panetta, Steven W Paugh, William E EvansFEBS Letters|November 5, 2003
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2Steven W Paugh, Shawn G Payne, Suzanne E Barbour, et al.Biochimica Et Biophysica Acta|September 26, 2006
Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseasesNitai C Hait, Carole A Oskeritzian, Steven W Paugh, et al.FEBS Letters|October 1, 2005
Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cellsSukumar Sarkar, Michael Maceyka, Nitai C Hait, et al.Molecular Pharmacology|March 31, 2006
Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptorSteven W Paugh, Michael P Cassidy, Hengjun He, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 26, 2008
Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signalDavid R Gude, Sergio E Alvarez, Steven W Paugh, et al.Cancer Research|November 3, 2007
Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicinHeidi M Sankala, Nitai C Hait, Steven W Paugh, et al.Pageof 3